Skip Navigation


JAC Advance Access originally published online on November 18, 2002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
50/6/1089    most recent
dkf213v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Manuel, R. J.
Right arrow Articles by Pallett, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manuel, R. J.
Right arrow Articles by Pallett, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2002) 50, 1089-1090
© 2002 The British Society for Antimicrobial Chemotherapy

Correspondence

Detection of teicoplanin resistance in UK EMRSA-17 strains

Rohini J. Manuel*, Andrew Tuck, Andrew Lowes and Ann Pallett

Southampton Public Health Laboratory, Level B, South Block, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK

The first 10% of the full text of this article appears below.

Keywords: MRSA, glycopeptide resistance

Sir,

The epidemiology of teicoplanin resistance in methicillin-resistant Staphylococcus aureus (MRSA) may be changing. In 2000, Aucken et al.1 reported on glycopeptide-intermediate S. aureus (GISA) strains obtained between May 1998 and December 1999 in England and Wales and concluded that it was not a major problem at that time. In the light of that letter, we thought it prudent to highlight our experience with GISA strains. In March 2000, the PHLS reported several isolates of MRSA from Southampton and Portsmouth that were intermediately resistant to . . . [Full Text of this Article]

Note added in proof


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
J. Cepeda, S. Hayman, T. Whitehouse, C. C. Kibbler, D. Livermore, M. Singer, and A. P. R. Wilson
Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit
J. Antimicrob. Chemother., September 1, 2003; 52(3): 533 - 534.
[Full Text] [PDF]